Zolpidem tartrate is a non-benzodiazepine receptor modulator primarily used in the FDA-approved short-term treatment of insomnia aimed at patients with difficulty falling asleep. [1] Zolpidem belongs to the control substance class C IV medicines and is regulated by the Drug Enforcement Agency.